The Importance of Screening for Thyroid Dysfunction During Pregnancy: Pathophysiological Background and Practical Implications
Authors:
J. Jiskra; Z. Límanová; E. Potluková; M. Antošová
Authors‘ workplace:
III. interní klinika 1. LF UK a VFN, Praha
Published in:
Čas. Lék. čes. 2007; 146: 827-833
Category:
Review Article
Overview
Thyroid hormones are essential both for the physiological course of pregnancy and for the optimal differentiation of the embryonic tissues and foetal brain development. Overt and subclinical hypothyroidism constitutes a frequent cause of infertility, it carries along an increased risk of spontaneous abortion and premature birth, and it may lead to an impaired foetal brain development resulting in a worse psychoneurological outcome in the progeny. The repeatedly documented high prevalence of thyroid diseases in pregnancy warrants a realization of systematic screening for thyroid dysfunction during early stage of pregnancy or better before conception whenever possible. The Czech Endocrine Society attempts to implement such a systematic screening in the Czech Republic, although the particular aspects of the screening are still discussed.
Key words:
pregnancy, thyroid stimulating hormone, thyroid dysfunction, antibodies to thyroid peroxidase.
Labels
Addictology Allergology and clinical immunology Angiology Audiology Clinical biochemistry Dermatology & STDs Paediatric gastroenterology Paediatric surgery Paediatric cardiology Paediatric neurology Paediatric ENT Paediatric psychiatry Paediatric rheumatology Diabetology Pharmacy Vascular surgery Pain management Dental HygienistArticle was published in
Journal of Czech Physicians
![Issue 11](https://www.prolekare.cz/media/cache/resolve/journal_issue/media/image_pdf/5f9d9078ccba51044d1ed7847da6618f.jpeg)
Most read in this issue
- Significance of Serum Antibodies ANCA, ASCA, ABBA in Diagnostics of Idiopathic Intestinal Inflammations
- Nutrigenetics and Nutrigenomics
- Thromboembolism in Pregnancy – Physiology and Pathophysiology of Hemocoagulation Changes During Normal and Pathological Gravidity
- Changes of Plasminogen Activator Inhibitor (PAI-1) During Estrogen Replacement Therapy